NCT00140985已完成4 期
A Randomized, Parallel, Double Blind Study of Losartan Versus Amlodipine in Patients With Mild to Moderate Hypertension and Chronic Nondiabetic Proteinuric Nephropathy: Evaluation of the Effect on Proteinuria and on the Plasmatic Levels of Growth Factors (TGFß and VEGF)
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 97
- 主要终点
- 24h proteinuria
研究概览
简要总结
Antiproteinuric Efficacy of Losartan Potassium in Patients with Non-Diabetic Proteinuric Renal Diseases.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Males or females at least 18 years of age with non-diabetic proteinuric renal diseases
排除标准
- 未提供
结局指标
主要结局
24h proteinuria
次要结局
- Changes in the plasma and urinary levels of TGF-beta
研究者
相似试验
已完成
不适用
Trial of Proteinuria Reduction Effect of Losartan/Hydrochlorothiazide Therapy to Chronic Kidney Disease with HypertensioChronic kidney disease patients with hypertensionJPRN-UMIN000001643Kyushu University Hospital Kidney Care Unit120
已完成
3 期
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED)NephropathyType 2 DiabetesNCT00308347Organon and Co1,513
已完成
3 期
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))ProteinuriaNCT00568178Organon and Co306
已完成
3 期
Efficacy and Safety of Losartan in Children With Ig A NephropathyGlomerulonephritis, IGANCT02232776Seoul National University Hospital37
已完成
4 期
Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes MellitusPROTEINURIAType 2 DiabetesHypertensionNCT00241085Novartis392